0001225208-23-002148.txt : 20230216
0001225208-23-002148.hdr.sgml : 20230216
20230216191547
ACCESSION NUMBER: 0001225208-23-002148
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230216
DATE AS OF CHANGE: 20230216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Brennan Daniel J.
CENTRAL INDEX KEY: 0001595612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 23639895
MAIL ADDRESS:
STREET 1: BOSTON SCIENTIFIC CORPORATION
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2023-02-15
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001595612
Brennan Daniel J.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP and CFO
Common Stock
2023-02-15
4
M
0
7572.0000
7.3900
A
280954.0000
D
Common Stock
2023-02-15
4
M
0
4153.0000
0.0000
A
285107.0000
D
Common Stock
2023-02-15
4
F
0
1219.0000
47.2900
D
283888.0000
D
Common Stock
2023-02-15
4
S
0
7572.0000
47.1378
D
276316.0000
D
Deferred Stock Units
2023-02-15
4
M
0
4153.0000
0.0000
D
2023-02-15
Common Stock
4153.0000
0.0000
D
Stock Option (Right to Buy)
7.3900
2023-02-15
4
M
0
7572.0000
0.0000
D
2023-02-28
Common Stock
7572.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.993 to $47.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 28, 2014, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2023-02-16